SCHEMBL7236134

SCHEMBL7236134

O=C(O)N1[C@@H]2CC[C@H]1C[C@@H](Nc1ccccc1[N+](=O)[O-])C2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.53
HCAR3 P49019 3/20 0.47
ALDH1A1 P00352 5/20 0.45
GAA P10253 3/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
CASP7 P55210 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAPT P10636 3/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 3/20 0.41
NPC1 O15118 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PKM P14618 1/20 0.41
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1573863 1.00 MAPK1 (0.53) MAPK1HCAR3ALDH1A1GAAMEN1
SCHEMBL1573866 1.00 MAPK1 (0.53) MAPK1HCAR3ALDH1A1GAAMEN1
SCHEMBL1573767 0.90 MAPK1 (0.48) MAPK1HCAR3ALDH1A1GAAMEN1
SCHEMBL1573769 0.90 MAPK1 (0.48) MAPK1HCAR3ALDH1A1GAAMEN1
SCHEMBL853692 0.84 HTR3E (0.55) MAPK1HCAR3ALDH1A1GAAMEN1
SCHEMBL853693 0.84 HTR3E (0.55) MAPK1HCAR3ALDH1A1GAAMEN1
SCHEMBL3082532 0.83 MEN1 (0.60) MAPK1HCAR3ALDH1A1GAAMEN1
SCHEMBL3082531 0.83 MEN1 (0.60) MAPK1HCAR3ALDH1A1GAAMEN1
SCHEMBL4015597 0.83 HCAR3 (0.41) MAPK1HCAR3ALDH1A1GAAMEN1
SCHEMBL3526469 0.83 HCAR3 (0.52) MAPK1HCAR3ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586430-B1 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders PFIZER INC. 2003-07-01 US disclosed